Dr. Syed N. Zafar, MD

Dr. Zafar practices at Wellstar Medical Group in Douglasville, Georgia.

Dr. Zafar's NPI, 1194824995, was assigned on September 21, 2006. Dr. Zafar holds Georgia license D58814.

Dr. Zafar's primary practice is Wellstar Medical Group, at 8820 Hospital Dr, Douglasville, GA 30134 in Douglas County. The practice phone is (470) 267-2433.

Dr. Zafar's primary practice is Wellstar Medical Group in Douglasville, Georgia. Dr. Zafar is also affiliated with Wellstar Douglas Medical Center. The medical group on file is Wellstar Medical Group. Dmand AI also links Dr. Zafar to 4 more hospitals, 3 home health agencies, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zafar practices, 10 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Zafar's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Zafar's licenses on file in 2 states: Georgia and Washington.

CMS data shows 1,168 Medicare services from Dr. Zafar across 14 procedure codes in 2024, for 327 Medicare patients. Medicare paid $92,207 for them. Every service was in an office.

CMS counts 327 Medicare patients who saw Dr. Zafar in 2024. The largest group is 65 to 74, with 151 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zafar's median patient age at 68, with 48% women.

In 2024, Dr. Zafar wrote 10,736 Medicare Part D claims for 876 patients. 84% of them were for generic drugs. CMS names the drug for 10,011 of them, across 142 drugs with 11 or more claims each, at $1,053,508 in total drug cost. In 2023, CMS named 10,864 claims across 148 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Zafar for performance year 2024, reported through an alternative payment model (APM). Dr. Zafar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 331 general payments to Dr. Zafar from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 73% of the total. Ipsen Biopharmaceuticals, Inc paid the most, $2,070.